文献速递乳房整形与再造美容整形

聚氨酯假体在乳房再次隆乳术中的应用:一项前瞻性5年研究

Polyurethane Implants in Revisional Breast Augmentation: A Prospective 5-Year Study.
PubMed 文献 · Aesthet Surg J · 2024-01-01

该前瞻性5年研究纳入78例(156侧乳房)接受假体修正的连续患者,评估聚氨酯假体在乳房再次隆乳术中的应用并提出算法。结果显示急性并发症率1.9%、远期再手术率4.5%、假体置换率0.6%,无复发性包膜挛缩。

要点

  • 聚氨酯假体在再次隆乳术中显示稳定性和低复发性包膜挛缩率。
  • 二次修正病例更多将假体从胸肌前改为胸肌后(P=.005)。
  • 三次修正病例更多将假体从胸肌后改为胸肌前(P=.002)。

核心结论

  • 聚氨酯假体在再次隆乳术中提供一致的稳定性,复发性包膜挛缩率低。

研究设计与样本

  • 前瞻性研究,为期5年,纳入连续接受假体修正的乳房再次隆乳术患者,共92例(184侧乳房),最终78例(156侧乳房)纳入分析。

主要发现

  • 平均年龄47.5岁,BMI 22.3,平均随访5年;63%为二次修正病例,37%为三次修正病例。
  • 假体平均尺寸296 cc,53%置于胸肌后,47%置于胸肌前。
  • 二次修正病例中更多假体从胸肌前改为胸肌后(P=.005),三次修正病例中更多从胸肌后改为胸肌前(P=.002)。
  • 完全包膜切除术占61.5%,部分包膜切除术占25.6%;32%附加脂肪填充,40%同期行乳房固定术。
  • 再次手术的急性并发症率为1.9%,远期再手术矫正率为4.5%,假体置换率为0.6%,无复发性包膜挛缩。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Revisional surgery for aesthetic breast augmentation remains a challenging procedure. Polyurethane (PU) implants have been found to avoid capsular contracture recurrence as well as to prevent implant displacement by bio-integrating with the pocket. OBJECTIVES: Our study aimed to assess the use of PU implants in breast revisional surgery and to provide an algorithm. METHODS: Over a 5-year period, a prospective study was conducted involving consecutive patients undergoing implant revision. Patient demographics, previous breast procedures, and specific surgical details were documented. Postoperative outcomes were followed up. RESULTS: Out of 92 patients (184 breasts), 78 (156 breasts) were included in the analysis. The average age was 47.5, with a BMI of 22.3 and a mean follow-up of 5 years. A majority (63%) represented secondary revisional cases, while 37% were tertiary cases. Implant size averaged 296 cc, with 53% placed in retropectoral position and 47% prepectoral. Significantly more implants in secondary cases were changed from prepectoral to retropectoral (P = .005), and in tertiary changed from retropectoral to prepectoral (P = .002). Complete capsulectomy was performed in 61.5% and partial in 25.6%. Additional lipofilling was performed in 32%, and concurrent mastopexy in 40%. Revisional surgery in our series had a 1.9% acute complication rate, 4.5% longer-term reoperation rate for corrections, 0.6% implant exchange rate, and no recurrent capsular contracture. CONCLUSIONS: This is the first study to provide data on outcomes of revisional breast augmentation surgery with PU implants. It shows that polyurethane implants offer consistent stability and have low rates of recurrent capsular contracture in revisional surgery.

来源:Aesthet Surg J,查看原文。版权归原作者所有。

引用

  1. Hamdi M, Kapila AK, Peters E, et al. Polyurethane Implants in Revisional Breast Augmentation: A Prospective 5-Year Study. Aesthet Surg J. 2024. PMID: 38408194. doi:10.1093/asj/sjae047

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。